These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31142059)

  • 1. Changes in uPA, PAI-1, and TGF-β Production during Breast Cancer Cell Interaction with Human Mesenchymal Stroma/Stem-Like Cells (MSC).
    Melzer C; von der Ohe J; Otterbein H; Ungefroren H; Hass R
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31142059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta 1 and sodium butyrate differentially modulate urokinase plasminogen activator and plasminogen activator inhibitor-1 in human breast normal and cancer cells.
    Dong-Le Bourhis X; Lambrecht V; Boilly B
    Br J Cancer; 1998; 77(3):396-403. PubMed ID: 9472634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells.
    Arnoletti JP; Albo D; Granick MS; Solomon MP; Castiglioni A; Rothman VL; Tuszynski GP
    Cancer; 1995 Sep; 76(6):998-1005. PubMed ID: 8625226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
    Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
    J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.
    Levenson AS; Kwaan HC; Svoboda KM; Weiss IM; Sakurai S; Jordan VC
    Br J Cancer; 1998 Jul; 78(1):88-95. PubMed ID: 9662256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo.
    Mandel K; Yang Y; Schambach A; Glage S; Otte A; Hass R
    Stem Cells Dev; 2013 Dec; 22(23):3114-27. PubMed ID: 23895436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.
    Wakahara K; Kobayashi H; Yagyu T; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    J Cell Biochem; 2004 Oct; 93(3):437-53. PubMed ID: 15372629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system.
    Ramont L; Pasco S; Hornebeck W; Maquart FX; Monboisse JC
    Exp Cell Res; 2003 Nov; 291(1):1-10. PubMed ID: 14597403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of transforming growth factor-beta on the plasminogen activator system in cultured first trimester human cytotrophoblasts.
    Graham CH
    Placenta; 1997; 18(2-3):137-43. PubMed ID: 9089774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced metastatic capacity of breast cancer cells after interaction and hybrid formation with mesenchymal stroma/stem cells (MSC).
    Melzer C; von der Ohe J; Hass R
    Cell Commun Signal; 2018 Jan; 16(1):2. PubMed ID: 29329589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings.
    Friess H; Duarte R; Kleeff J; Fukuda A; Tang WH; Graber H; Schilling M; Zimmermann A; Korc M; Büchler MW
    Surgery; 1998 Jul; 124(1):79-86. PubMed ID: 9663255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type 1 in pancreatic cancer.
    Albo D; Berger DH; Vogel J; Tuszynski GP
    J Gastrointest Surg; 1999; 3(4):411-7. PubMed ID: 10482694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous Fusion of MSC with Breast Cancer Cells Can Generate Tumor Dormancy.
    Melzer C; Ohe JV; Luo T; Hass R
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta stimulates urokinase expression in tumor-associated macrophages of the breast.
    Hildenbrand R; Jansen C; Wolf G; Böhme B; Berger S; von Minckwitz G; Hörlin A; Kaufmann M; Stutte HJ
    Lab Invest; 1998 Jan; 78(1):59-71. PubMed ID: 9461122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Epigallocatechin gallate derivatives reduce the expression of both urokinase plasminogen activator and plasminogen activator inhibitor-1 to inhibit migration, adhesion, and invasion of MDA-MB-231 cells.
    Shin S; Kim MK; Jung W; Chong Y
    Phytother Res; 2018 Oct; 32(10):2086-2096. PubMed ID: 30009577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.
    Lundgren CH; Sawa H; Sobel BE; Fujii S
    Circulation; 1994 Oct; 90(4):1927-34. PubMed ID: 7923681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of spontaneous and TGF-β-induced cell motility of primary human normal and neoplastic mammary cells in vitro using novel real-time technology.
    Mandel K; Seidl D; Rades D; Lehnert H; Gieseler F; Hass R; Ungefroren H
    PLoS One; 2013; 8(2):e56591. PubMed ID: 23457587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact.
    Hildenbrand R; Schaaf A; Dorn-Beineke A; Allgayer H; Sütterlin M; Marx A; Stroebel P
    Histol Histopathol; 2009 Jul; 24(7):869-77. PubMed ID: 19475533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.